Why Astronics (ATRO) Is Down 16.5% After Hiking 2026 Revenue Guidance And Backlog Outlook

• Astronics Corporation recently reported that second-quarter 2026 sales rose to US$259.96 million, with net income increasing to US$35.06 million, and it issued third-quarter sales guidance of US$265 million to US$275 million while raising full-year 2026 revenue expectations to US$1.02 billion–US$1.04 billion.

• The company also highlighted a record US$780.6 million backlog at the end of the second quarter, with around 82% expected to convert to revenue over the next twelve months, underscoring substantial contracted demand across its aerospace and defense end markets.

• We'll now examine how Astronics' raised full-year 2026 revenue guidance may reshape its existing investment narrative and future expectations.

AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery . The best part - they are all under $10b in market cap - there's still time to get in early.

Astronics Investment Narrative Recap

Astronics appeals to investors who believe in sustained demand for its aerospace and defense electronics, backed by contracted revenue and improving profitability. The raised 2026 revenue guidance and strong Q2 results support that thesis in the near term, while also sharpening focus on the biggest current risk: execution missteps or cost overruns that could erode margins just as volumes and expectations are rising. At this stage, the latest guidance appears supportive rather than transformative for the short term story.

Among recent announcements, the record US$780.6 million backlog, with roughly 82% expected to turn into revenue over the next twelve months, feels most relevant. It directly connects to the higher full year 2026 guidance and near term sales targets, reinforcing the importance of timely deliveries and clean program execution as a key catalyst, but also a pressure point if operational issues in areas like the Test segment resurface.

Yet alongside the strong guidance headline, investors should also be aware of the lingering execution risk in Test and how it could intersect with...

Read the full narrative on Astronics (it's free!)

Astronics' narrative projects $1.1 billion revenue and $188.4 million earnings by 2029.

Uncover how Astronics' forecasts yield a $85.98 fair value , a 10% upside to its current price.

Exploring Other Perspectives

While consensus is cautious, the most optimistic analysts were already penciling in revenue of about US$1.1 billion and earnings near US$188.7 million, so this fresh guidance could either strengthen that upbeat view or prompt a rethink if you worry that customer concentration risk remains underappreciated.